This email may contain information that is confidential and/or protected by law and is intended solely for the use of the individual or entity to whom it is addressed. If you have received this email in error or without being its named addressee, please immediately notify the sender (EGIS Pharmaceuticals PLC, phone: +36-1-265-5555) and delete this e-mail from your system. If you are not the intended recipient you are notified that disclosing, copying, distributing or using the contents of this email in any unauthorised way is strictly prohibited. As this email is primarily for the provision of information EGIS PLC accepts no liability for its content, unless that content is subsequently confirmed by the company in writing.